Helicobacter pylori infection is associated with an increased risk for development of duodenal ulcers, gastric ulcers, gastric adenocarcinomas and gastric lymphomas. However, resistant strains have developed because of antibiotic treatment. In this study, the water, acetone, chloroform and methanol extracts of two Solancaceae plants, Solanum erianthum and Solanum torvum (ST), were tested for their anti-H. pylori activity. All of ST extracts were able to inhibit the growth of H. pylori and showed better activities against antibiotic strains than the reference strain. Among them, chloroform extract of ST (ST-C) possessed the strongest ability to inhibit H. pylori growth. Association assay was performed by the ST-C showing that ST-C was able to interrupt the association of bacteria to host cells. Furthermore, H. pylori-induced apoptosis could also be efficiently suppressed by the ST-C. It was able to interfere with the interaction between bacteria and host cells and also target H. pylori-induced gastric injury by suppressing apoptosis. Therefore, ST-C may offer a new approach for the treatment of H. pylori. Further studies on the elucidation of the molecular mechanisms of the growth inhibition on H. pylori by ST-C, and to identify active compounds in the plants are in progress.
Introduction
The Gram-negative bacterium Helicobacter pylori persistently colonizes the human stomach (1, 2) . H. pylori-induced gastric inflammation might not cause symptoms in most infected persons, but is associated with an increased risk for development of duodenal ulcers, gastric ulcers, gastric adenocarcinomas and gastric lymphomas. Therefore, H. pylori has been classified as a group 1 carcinogen (3, 4) .
Many studies have showed that apoptosis plays an important role in the pathogenesis of various diseases (5) . Homeostasis in the stomach is maintained through a balance between gastric epithelial proliferation and apoptosis (6) . However, H. pylori infection affects the normal balance (6) (7) (8) (9) (10) (11) . In patients with gastric cancer, there is a disturbance in Bax (the pro-apoptotic protein) and Bcl-2 (the anti-apoptotic protein) balance induced by H. pylori (9) . Several studies reported that the release of apoptosis-inducing factor from mitochondria is the major pathway involved in H. pyloriinduced apoptosis (10, 11) .
In order to eliminate H. pylori infection, several treatments including at least one antibiotic in combination with a proton pump inhibitors have been applied (12) . However, as other bacterial pathogens, antibiotic resistance to H. pylori is an increasing problem for eradicating infection (13) . Therefore, finding a safe and efficient treatment to decrease the need or even replace antibiotics for eradicating H. pylori infection in human becomes necessary and an important task.
The Solancaceae family of plants is one of the three most important vegetable crops relevant to human nutrition and health (14) . These crops produce biologically active secondary metabolites, such as alkaloids, flavonoids and terpenoids, which have beneficial effects in the diet. Alkaloids have anticancer activities (15) (16) (17) (18) . Flavonoids are anti-oxidation agents which can eliminate free radicals and suppress antibacterial ability (19) (20) (21) (22) . Terpenoids are extensively used for their aromatic qualities. They all play important roles in traditional herbal remedies and are under investigation for anti-bacterial, anti-neoplastic and other pharmaceutical effects (23) (24) (25) (26) .
In this study, two Solancaceae plants, Solanum erianthum and Solanum torvum (ST) which are all valued folk herbal medicine tested against the pathogen H. pylori. SE is used for treatment of metrorrhagia, edema, gout, carbuncles, eczema, toothache and dermatitis (27) . The fruit juice of ST is used for the treatment of abscesses, jigger wounds, and skin infections. ST was used as a tonic and haemopoietic agents and for treatment of pain (28) . This study was aimed at evaluating the anti-microbial activity and the effects of the (29, 30) . These strains are all resistant to both metronidazole and clarithromycin, the antibiotics used to treat H. pylori infection. H. pylori was grown on blood agars under microaerophilic conditions at 37˚C for 48-72 h. AGS cell line (ATCC CRL 1739; human gastric adenocarcinoma cell line) was purchased from the ATCC and was cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) and antibiotics (100 U/ml of penicillin and 100 μg/ml of streptomycin).
Anti-microbial activity. Disc diffusion method was applied to determine the anti-microbial activity of plant extracts. A suspension of the H. pylori (1x10 5 cells) was spread on Mueller-Hinton agar plates supplemented with 5% sheep blood. Filter paper discs (6 mm in diameter) were impregnated with 10 μl of plant extracts and antibiotics and placed on the inoculated plates. These plates were incubated at 37˚C for 48-72 h. The diameters of the inhibition zones were measured in mm. All the tests were replicated four times and the antibacterial activity was expressed as the mean of inhibition diameters (mm) produced by the plant extracts.
Cell viability assay. AGS cells were seeded onto 24-well plates at a density of 5x10 4 cells/well for 24 h. Indicated concentration of plant extracts were then added to the cells, while only adding 0.1% DMSO (solvent) in the control group and grown at 37˚C for 24 h. For determination of cell viability, the trypan blue exclusion protocol was used. Briefly, ~10 μl of cell suspensions in phosphate-buffered saline (PBS, pH 7.4) were mixed with 40 μl of trypan blue and the numbers of stained (dead cells) and unstained cells (live cells) were counted using a hemocytometer. The cell viability was calculated as the percentage of cell survival after the treatment.
Association assay. AGS cells cocultured with PBS-resuspended
H. pylori at the multiplicities of infection (MOI) of 100 were treated with plant extracts in the antibiotics-free RPMI-1640 supplemented with 10% FBS. Indicated concentration of plant extracts were then added to the cells, while only adding 0.1% DMSO (solvent) in the control group. Cell-associated bacteria were quantified 6 h after infection by osmotic lysis of host cells. Cell culture supernatants were removed gently, cells were washed with PBS and osmotic lysis was performed to calculate the total amount of bacteria. For this purpose, sterile water was added to infected cells after washing and cell lysates were resuspened with PBS and bacterial numbers were determined by plating serial dilutions on chocolate agar plates. The association activity was determined as the mean of triplicates. The bacteria associated with host cells included adherent and invaded ones. The results were expressed as the percentage of relative association of H. pylori as compared with the control group. Proteins were transferred to a PVDF membrane (Hybond-P, Amersham) according to the manufacturer's instructions. Following the transfer, the membrane was washed with PBS and blocked for 1 h at 37˚C with 5% fat-free milk in PBS and 0.1% of Tween-20 (PBST). The primary antibody (ß-actin, caspase-8, Bid, Bad, Bax, cytochrome c, caspase-9 and caspase-3; Santa Cruz Biotechnology, USA) was added at a dilution of 1/10000. Blots were incubated with the peroxidaseconjugated secondary antibodies (horseradish peroxidaseconjugated goat anti-mouse IgG and goat anti-rabbit IgG; Santa Cruz Biotechnology) at a dilution of 1/1000. Following removal of the secondary antibody, blots were washed by PBST and developed by ECL-Western blotting system (Pierce, Rockford, IL, USA). Densities of the obtained immunoblots were quantified by Kodak digital science 1D (ver. 2.03) (Kodak, Rochester, NY, USA).
Preparation of cell extracts and
Statistical analysis. The differences between Solancaceae plant extract-treated and control groups in mean values were evaluated by Student's t-test using the SPSS software program (SPSS Inc., Chicago, IL, USA). Differences with a P<0.05 were considered significant.
Results

SE and ST extracts inhibit H. pylori growth.
The water (W), acetone (A), chloroform (C) and methanol (M) extracts of SE and ST at concentrations of 50-2.5 mg/ml were all tested for their anti-H. pylori activity based on the disc diffusion method. DMSO (0.1% v/v) was used as negative control and showed no effect. As shown in Table I , the ST extracts were more active than SE extracts. The chloroform extract of ST (ST-C) exhibited the strongest anti-microbial activity against the reference strain. It was able to inhibit H. pylori at the concentration of 5 mg/ml with 9 mm of inhibition zone. The SE extracts were not effective against the reference strain, even up to the concentration of 50 mg/ml of the plant extracts.
Based on the inhibitory activity against H. pylori reference strain, we tested the activity of SE and ST extracts also against four clinical strains (Table II) . Those analyzed strains were isolated from H. pylori-positive patients who failed in a triple treatment (lansoprazole, clarithromycin and metronidazole) (29) and those strains were also tested for multiple drug-resistant (30) . As we expected, all the clinical isolates were resistant to clarithromycin (CLR) at 0.05 mg/ml and metronidazole (MTZ) at 0.8 ml/ml, while reference strain was sensitive to both antibiotics with inhibition zone of 44.25 mm (CLR) and 31 mm (MTZ). All of the ST extracts were able to inhibit the growth of all H. pylori strains at 50 mg/ml. ST-W could even inhibit strain V2356 with a 20.5 mm-zone. ST-C also showed better activities against clinical strains than reference strains. Interestingly, the organic solvent extracts of SE (SE-M, SE-A and SE-C) did not possess inhibitory activity against reference strain at concentration of 50 mg/ml, however, they showed stronger activity against multidrug-resistant strains with inhibition zone of 10.5-13 mm. Among all the plant extracts, ST-C was the best for eradicating H. pylori infection.
Viability of AGS cells after treated with ST-C.
Based on the anti-microbial activity, ST-C was found to have strong activity against H. pylori. In order to determine the treating dosage of ST-C, the viability of AGS cells was performed. ST-C at 32 μg/ml significantly decreased 57% of the viable cells (Fig. 1) . At the concentration of 8 μg/ml, 95% of AGS cells were not affected after 24 h treatment. To investigate the effect of ST-C on interaction between AGS cells and H. pylori, the low-toxic dosage of ST-C (<32 μg/ml) was chosen for further assays.
ST-C inhibited the association of H. pylori to AGS cells.
We further analyzed the effect of ST-C on association of H. pylori to AGS cells (Fig. 2) . ST-C treatment significantly decreased the association of H. pylori to AGS cells. At the concentration of 5 μg/ml, it showed a 57% decrease. However, there was no significant difference in inhibiting bacteria association within the dose range of 5-20 μg/ml and the cell viability was not affected at this range.
ST-C suppressed H. pylori-mediated apoptosis in AGS cells.
We further examined that the effect of ST-C on H. pylorimediated apoptosis in AGS cells. The expression of caspase-8, Table I . Effects of plant extracts against H. pylori reference strain. Plant extract  50  25  10  5 2. 5  ----------------------------------------------- -
The amount of plant extracts in a disc was 50 mg/ml. b 0.05 mg/ml of clarithromycin. c 0.8 mg/ml of metronidazole. Bid, Bad, Bax, cytochrome c, caspase-9 and caspase-3 in infected cells were monitored (Fig. 3) . Compared with untreated cells, ST-C significantly suppressed the expression of caspase-8, Bid, Bad, cytochrome c, caspase-9 and caspase-3 in a dose-dependent manner. However, the expression of the anti-apoptotic protein Bax was up-regulated. These data indicated that ST-C treatment could block H. pylori-mediated apoptosis in AGS cells.
Discussion
S. torvum (ST) is one of the most valued folk herbal medicines for treatment of abscesses, jigger wounds, skin infections and has been used as a tonic and haemopoietic agents and for treatment of pain (28) . This is the first study to show that the chloroform extract of ST (ST-C) strongly inhibits H. pylori growth and also interrupts the association of bacteria to host cells. H. pylori-induced apoptosis was also efficiently suppressed by the extract.
Several treatments are used as a means to eradicate H. pylori infection, all include at least one antibiotic in combination with a proton pump inhibitor (2, 12) . The effectiveness of the treatment has been impaired by increasing drug resistance strains (13, 31) . In this study, ST-C showed a strong ability in inhibiting the growth of H. pylori, including multidrug-resistant strains which were isolated from H. pyloripositive patients who failed in a triple treatment. The association of H. pylori to AGS cells was also interrupted by ST-C. Several studies have showed that apoptosis plays an important role in the pathogenesis of various diseases (5) . It has been showed that H. pylori induced apoptosis in epithelial cells mainly through the death receptor leading to the cleavage of pro-caspase-8 and Bid, release of chytochrome c from mitochondria and activation of subsequent downstream apoptotic pathway (10, 11) . ST-C was able to interfere with the interaction between bacteria and host cells and also target H. pylori induced gastric injury by suppressing apoptosis (Fig. 4) , therefore, ST-C may offer a new approach for the treatment of H. pylori. Further studies on the elucidation the molecular mechanisms of the growth inhibition on H. pylori by ST-C and to identify active compounds in the plants are in progress.
